Home › Kanser sa Tiyan › Texas › Austin

Pag-aaral pangklinika para sa Kanser sa Tiyan sa Austin, TX

Isang pag-aaral para sa Kanser sa Tiyan ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology, Austin

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Nagre-recruitPhase 2/3

Texas Oncology-Austin Central, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07221149

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Nagre-recruitPhase 1/2

Texas Oncology (Balcones) - SCRI, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Nagre-recruitPhase 1

NEXT Oncology - Austin, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06253871

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Nagre-recruitPhase 1

NEXT Austin, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07227168

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

Texas Oncology - Central South, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06657144

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Nagre-recruitPhase 1

NEXT Oncology Austin /ID# 243005, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05005403

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Nagre-recruitPhase 3

Texas Oncology Central South (SCRI), Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06532006

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Elligo Health Research, Inc., Austin

Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

Pag-aaral para sa Kanser sa Tiyan sa ibang lungsod

Iba pang pag-aaral sa Austin

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.